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Abstract
Background:  Histology and/or culture are generally considered the gold standard for the
detection of H. pylori infection. Especially in children, these tests may result in a false negative
outcome because of patchy distribution of the organism in the stomach mucosa. We have
developed a PCR assay utilizing nested primer pairs directed against a subunit of the H. pylori urease
gene (ureA). As part of a prospective evaluation of diagnostic tests to aid in detecting H. pylori
infection in children, the aim of this study was to compare our PCR and Western blot assays with
results obtained from histologic examination of biopsy specimens, rapid urease tests, and an FDA
approved serologic assay and published PCR results to determine if we could validate the assays
for diagnostic use on our patient population.
Results: Gastric biopsy specimens obtained from 101 pediatric patients were evaluated for the
presence of H. pylori using histologic techniques, rapid urease (CLOtest) test and the PCR assay.
Serum samples from each patient were assayed using both ELISA and Western Blot for antibodies
to H. pylori. A total of 32 patients tested were positive by at least one of the methods evaluated.
Thirteen patients had positive histology, 13 had a positive CLOtest, and 17 patients had positive H.
pylori PCR. Out of the 13 CLO positive patients, 12 were positive by histologic analysis and all 13
were positive by PCR. Results of serologic tests on the same population did not correlate well with
other assays. Twenty-eight patients showed serologic evidence of H. pylori infection, of which 9
were both CLO and histology positive and 12 were positive by PCR. Of the seropositive patients,
26 were ELISA positive, 13 were positive by Western blot, and 11 by both serologic methods.
Conclusions: The results obtained suggest that our nested PCR assay has the specificity and
sensitivity necessary for clinical application when compared to standard histologic examination and
rapid urease test. In addition, we found the current commercially available approved ELISA method
appears unable to accurately detect H. pylori in this population. The Western blot assay yielded
better concordance with CLOtest and histology, but not as good as the nested PCR assay.
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Background
Helicobacter pylori is a gram-negative curved or spiral bac-
terium which colonizes the human gastric mucosa. Work
by Warren and Marshall in the early 1980s demonstrated
the organism's association with gastritis and peptic ulcer-
ation. Chronic H. pylori infection has also been linked to
the development of gastric cancers [1-3].
Diagnosis of H. pylori infection generally includes a com-
bination of both invasive and non-invasive methods.
Invasive tests include endoscopy, with biopsy of the
affected region followed by histologic examination of
stained specimens to demonstrate the presence of the bac-
terium and culture of the bacterium from the tissue. Cul-
ture of the organism, although not routinely performed, is
considered the gold standard for the diagnosis of H. pylori
infection. Biopsy specimens are also used to detect the
presence of the H. pylori urease. This biopsy urease test
(Campylobacter-like organism or CLOtest) is considered
rapid and economical, and is in widespread use in clinical
practice. Non-invasive tests include detection of the bacte-
rial urease by the 13C- or 14C-urea breath tests, which can
be expensive and may involve exposure to radioactivity,
and serologic testing of the patient's serum to detect IgG
and IgA antibody response to the organism [4-6].
Recently, a rapid EIA to detect H. pylori antigen in stool
has also become available [7].
Polymerase chain reaction (PCR) has been demonstrated
to be a reliable and highly sensitive tool for detection of
bacterial gene sequences in a variety of clinical specimens.
Samples used in PCR assays to detect H. pylori include gas-
tric biopsies, saliva, dental plaque, and stool, although the
latter has met with mixed success [8-10]. As part of a pro-
spective evaluation of tests used to diagnose H. pylori
infection in the pediatric population, we developed a PCR
assay to detect H. pylori sequences in gastric biopsy speci-
mens from children undergoing upper endoscopy.
Patients included in this study were all assessed for H.
pylori infection as part of their physician's suspicion of H.
pylori infection or as part of a rule out for another diagno-
sis. The PCR assay uses a nested set of primer pairs
directed against a region of the urease A gene. Results
obtained using this assay were compared to those
obtained by histologic examination of hematoxylin-eosin
stained gastric biopsy specimens, CLOtest, serologic anal-
yses including ELISA and Western Blot, and results of pub-
lished studies using similar methods.
Gastric mucosal biopsy specimens from pediatric patients
were evaluated for the presence of H. pylori by standard
histologic techniques, CLOtest, and our nested PCR assay.
Serum samples from each patient were tested for antibod-
ies to H. pylori by ELISA and by an in-house Western Blot
assay. Our results indicate that while the nested PCR assay
correlates well with results obtained using other invasive
tests and has the sensitivity and specificity necessary for
routine clinical use, results of current serologic methods
may not accurately reflect the H. pylori status of pediatric
patients.
Results
Complete data for this study was obtained on 101 pediat-
ric patients (49 males, 52 females). Three patients had
samples taken from two separate locations at the time of
biopsy while one patient underwent endoscopic examina-
tion twice in a four month time period, yielding 105 biop-
sies and 102 serum samples for testing. Of these 105
samples, a total of 34 (32.4%) gave positive results for at
least one of the methods examined (Figure 1). Fourteen
samples were both CLOtest positive (13.3%) and positive
by our nested PCR assay. Fourteen biopsies were positive
by histologic staining (13.3%), of which 2 gave a negative
result by PCR. A total of 18 samples were positive by the
nested PCR assay (17.1%). Patient samples were consid-
ered to be positive for H. pylori by PCR amplification if the
279 bp band was seen in the initial reaction and/or the
120 bp was seen in the internal nested reaction. Of the 18
PCR positive samples, 12 showed both the 279 and the
120 bp bands, while the remaining 6 gave a positive reac-
tion only after the internal nested amplification. When
invasive methods were considered together, 20 samples
were positive by one or more of these tests (19.0%).
Twenty-eight (27.4%) of the matching serum specimens
on this patient population showed reactivity to H. pylori.
Of these, 26 were positive by ELISA, 13 were positive by
Western blot, and 11 were positive by both serologic
methods. For 14 (13.3%) of the serum samples, serologic
testing yielded the only H. pylori positive results. Interest-
ingly, one patient had clearly negative CLOtest and PCR
results, while the histologic examination of both of this
child's biopsies (obtained from endoscopies performed
on two separate dates) showed the presence of organisms
consistent with H. pylori. At both examination dates, both
ELISA and Western blot on this patient were also positive.
Conversely, our PCR assay yielded the only positive result
for another patient shown included in the study. Using
our nested assay, we were able to detect H. pylori-specific
sequences at an estimated concentration of 1 picogram
(pg) after just the initial round of amplification. This cor-
responds to approximately 540 H. pylori bacteria, based
on a size of 1.67 Mbp for the complete H. pylori genome
[11]. Amplification of the internal gene segment using the
nested primer pair further increased the reliable detection
limit sensitivity to approximately 30 femtograms (fg), cor-
responding to about 16 bacterial genomes.
As culture of H. pylori from biopsy specimens was not per-
formed in our study, other methods based on endoscopic
examination (specifically CLOtest and histologic stainingBMC Microbiology 2004, 4 http://www.biomedcentral.com/1471-2180/4/5
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Results of patient testing for H. pylori Figure 1
Results of patient testing for H. pylori. Results of all testing (including biopsy-based methods and serology) are shown for 
the thirty-four samples included in the study which gave at least one positive result. Samples 20 and 21 were biopsies collected 
during endoscopic examinations performed 4 months apart on the same patient. Matched serum samples for this patient were 
obtained at each visit. Sample 31 was a biopsy collected from the antrum of a patient undergoing endoscopy, while sample 32 
was from the body of the stomach of the same patient. Only one serum sample from this patient was received for analysis. The 
remaining sixty-seven patients (71 samples) were negative for all assays performed (data not shown). The BIOPSY column 
includes all specimens for which at least one test result was positive (CLOtest, PCR, or histology). The SEROLOGY column 
includes all serum samples considered reactive by either H. pylori ELISA (IgG and/or IgA), Western Blot (IgG and/or IgA), or 
both.
S
A
M
P
L
E
 
I
D
C
L
O
t
e
s
t
P
C
R
H
I
S
T
O
L
O
G
Y
B
I
O
P
S
Y
S
E
R
O
L
O
G
Y
1 - - - - +
2 - - - - +
3 - - - - +
4 + + + + +
5 + + + + +
6 - + - + +
7 - + - + -
8 - - - - +
9 + + + + -
10 + + + + +
11 - - - - +
12 - - - - +
13 - - - - +
14 + + + + -
15 - - - - +
16 + + + + -
17 - + - + +
18 - - - - +
19 + + + + +
20 - - + + +
21 - - + + +
22 - - - - +
23 + + + + +
24 - - - - +
25 + + + + +
26 - - - - +
27 + + + + -
28 - + - + +
29 - + - + +
30 - - - - +
31 + + - + +
32 + + + +
33 - - - - +
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of the biopsy specimens) were considered the gold stand-
ard for determination of the sensitivity and specificity of
the PCR and serologic assays. Based on the stated criteria,
12 of the patients examined as part of this study (11.9%)
were diagnosed as H. pylori infected. Overall, the invasive
methods were shown to be more sensitive and specific
than the serologic methods used for this population. The
data indicates identical sensitivity and comparable specif-
icity of the nested PCR assay compared to the widely used
gold standard methods (Figure 2).
Discussion
It is generally accepted that most H. pylori infections are
acquired in childhood or adolescence, and it has been
postulated that infection with this common pathogen at a
young age increases the risk of H. pylori-related complica-
tions later in life. In light of these issues, accurate diagno-
sis of infection with H. pylori is important in the
symptomatic pediatric patient. In this study, we examined
the clinical usefulness of a both a nested PCR assay devel-
oped in-house to detect H. pylori sequences in pediatric
gastric biopsy specimens, and an in-house Western blot
assay for H. pylori. We compared these assays to com-
monly used FDA approved tests to diagnose infection
with this organism.
One hundred and one children undergoing endoscopy
were tested using invasive (biopsy-based) methods and
non-invasive (serologic) tests. Each of the assays exam-
ined has some limitations associated with its use, as evi-
denced by the results observed for a number of patients
included in the study. Of the 101 pediatric patients tested,
Sensitivity and specificity of the test methods evaluated for detection of H. pylori infection Figure 2
Sensitivity and specificity of the test methods evaluated for detection of H. pylori infection. The sensitivity and 
specificity of each test method was compared to our accepted biopsy gold standard – patients were considered to be infected 
with H. pylori if both rapid urease and histology tests were positive.
N
 BIOPSY                  
POSITIVE          NEGATIVE 
SENSITIVITY 
(%)
SPECIFICITY 
(%)
CLOtest + 14 13                                  1 100 98.9
- 91 0                                  91 
total ## 13                                 92
HISTOLOGY + 14 12                                   2  100 97.8
- 91 0                                   91 
total ## 12                                 93
PCR + 18 13                                   5  100 94.6
- 87 0                                  87 
total ## 13                                 92
SEROLOGY + 29 9                                  20  69.2 78.2
- 76 4                                  72 
total ## 13                                 92 BMC Microbiology 2004, 4 http://www.biomedcentral.com/1471-2180/4/5
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12 were considered to be positive based on established
criteria, but only 7 of those were positive by all of the
methods used. Results observed using these invasive
methods could be influenced by a variety of factors,
including load and distribution of the organism, virulence
and urease production in the infecting strain, and pathol-
ogist experience.
In general, CLOtest and histology showed the best corre-
lation and proved to be the most sensitive and specific
methods. None of the biopsy samples tested were positive
by CLOtest only; all samples positive in the rapid urease
test were also PCR positive, and all but one were positive
by histological examination. One patient included in the
study (each of two samples obtained 4 months apart) was
positive only by histology. Matching serum samples were
positive at both time points. Nested PCR directed against
ureA also showed good correlation with the established
biopsy methods. For five of the patients, PCR was the only
biopsy-based test yielding positive results, while four of
these children were also positive by serologic methods.
Our data indicate that our nested assay has comparable
sensitivity (100%) and specificity (94.6%) to the biopsy-
based methods currently available, results in line with
previously published reports for molecular diagnostic
methods [9,10,12].
Review of the current literature reveals that in general,
commercially available serologic assays for diagnosis of
H. pylori are limited in their ability to reliably detect the
infection in children [3,12]. Our data appears to support
this, as the commercial serologic assay in use in our labo-
ratory was shown to be less sensitive (46% of CLOtest and
histology positives were identified as such) in our patient
population compared to the invasive methods studied. In
our patient population, immunologic reactivity to H.
pylori was seen in 28 patients, however only 9 of those met
the established criteria selected for documented infection.
In four cases, all testing on biopsy specimens gave positive
results, but the corresponding serologic assays were
shown to be negative. Fourteen of the serums that showed
reactivity matched to biopsy samples proven to be nega-
tive, further supporting the use of established invasive
methods for accurate detection. The Western blot assay
appeared to yield improved results, detecting 69.2% of
the defined positives as such with 4 (31%) probable false
positives, versus 14 (54%) for the commercial ELISA.
PCR is currently considered a research tool in the H. pylori
arena, although a number of studies have been performed
using primers directed against a variety of bacteria-specific
sequences and several different sample types from saliva
to stool. Our data suggests that our in-house nested assay
would be an accurate and reliable tool for the detection of
H. pylori infection in the pediatric population. In addition,
our simplified boiling method alleviates the need for
expensive and time-consuming DNA isolation procedures
while still allowing detection of specific bacterial
sequences. Although at this time this assay is based on an
invasive diagnostic procedure, further studies need to be
performed to validate its use in a non-invasive manner,
while maintaining levels of sensitivity and specificity.
Conclusions
◆  Results of the nested PCR assay for detection of the Heli-
cobacter pylori urease A gene in pediatric gastric biopsies
show good correlation with results obtained from
CLOtest slides and histologic examination.
◆  The data show a statistically significant difference
between number of positive results obtained through
invasive procedures (biopsy followed by CLOtest, histol-
ogy, and PCR) and those obtained using serology (p =
0.038).
◆  Compared to CLOtest and histology as the standard for
proven Helicobacter pylori infection, the nested PCR assay
was shown to have a sensitivity of 100% and a specificity
of 94.6%. These results suggest that the nested assay
would be a reliable tool for clinical use in the detection of
Helicobacter pylori infections.
Methods
Clinical Specimens
Gastric Biopsy Tissue
A total of 105 biopsy specimens from 101 pediatric
patients (49 males, 52 females) undergoing upper endos-
copy at the A. I. DuPont Hospital for Children were
obtained from the Gastroenterology Laboratory. Speci-
mens were received in CLOtest slides (Ballard Medical
Products, Draper, UT), the CLOtest result was recorded,
and samples were processed for PCR analysis. Briefly,
biopsy tissue was removed from the gel matrix of the slide
and washed three times with sterile distilled water. A final
aliquot of distilled water was added and samples were
boiled for 10 minutes. Samples were centrifuged to collect
the tissue and the supernatant was removed to a sterile
microcentrifuge tube for use in PCR analysis. All samples
were stored at -70°C until tested.
Serum
Serum samples for H. pylori testing were received in the
Immunology Laboratory at the time of endoscopy or
within one month of the procedure. Serologic detection of
H. pylori-specific IgG and IgA antibodies was performed
using both a commercially available ELISA kit and an in-
house Western Blot method.BMC Microbiology 2004, 4 http://www.biomedcentral.com/1471-2180/4/5
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ELISA
ELISA tests were performed using the GAP-IgG and GAP-
IgA ELISA test kits (Biomerica, Newport Beach, CA)
according to the manufacturer's instructions.
Western Blot
For in-house production of the Western Blot test strips, H.
pylori (ATCC strain 43504) grown on Skirrows medium
(BD Biosciences, Sparks, MD) was harvested, washed, and
resuspended in PBS with 5 mM MgCl2. Total protein con-
centration was determined using a Bradford microassay
(BioRad, Richmond, CA). Harvested bacteria were diluted
to a concentration of 4.0 mg/ml in sample buffer contain-
ing 0.1 M dithiothreitol and electrophoresed in 11%
denaturing polyacrylamide gels using a modification of
the procedure of Laemmli [13]. Separated antigens were
transferred to nitrocellulose membranes (Schleicher and
Schuell, Keene, NH) that were subsequently blocked in
PBS containing 0.5% BSA, dried, cut into strips, and
stored dessicated until testing was performed. Sera were
tested for IgG and IgA antibodies by incubating the strips
with a 1:200 dilution of test serum in PBS containing 1%
nonfat dry milk for 1 hour at room temperature. Strips
were washed and then incubated with a 1:1000 dilution
of biotinylated antisera (goat anti-human IgG or goat
anti-human IgA; Kirkegaard and Perry Laboratories,
Gaithersburg, MD) for 1 hour at room temperature. The
strips were washed again and incubated with a 1:1000
dilution of peroxidase-conjugated streptavidin (Kirke-
gaard and Perry Laboratories) for 1 hour. Strips were
washed and incubated with 4-chloro-1-napthol substrate
(7.8 mM 4-chloro-1-napthol diluted 1:2 with a 1:1500
dilution of 30% H2O2 in citrate phosphate buffer). The
reaction was stopped with distilled water, the strips were
air-dried, and banding patterns were evaluated.
Polymerase chain reaction (PCR)
PCR was carried out in a Perkin Elmer 9600 thermocycler
(Foster City, CA) using 10 µl boiled supernatant (pre-
pared as described above) as the sample in each 100 µl
reaction. Control reactions contained 10 ng purified H.
pylori DNA (ATCC strain 43504) in a 100 µl reaction. Oli-
gonucleotide primers used were purchased from Inte-
grated DNA Technologies (Coralville, IA).
Oligonucleotides HpF1 (5' GATAAG TTGATGCTCCA
CTACGCTG 3') and HpB25 (5' CTCAATAGG GGTAT-
GCACG GTTAC 3') were used to amplify a 279 nucleotide
(nt) product of the H. pylori urease A gene. Oligonucle-
otides HpF2 (5' AAGCAGTAGCTTTGATTAGTG CCC 3')
and HpB5 (5'CGCCATCCATC ACATCATCTG 3') are
internal to HpF1 and HpB25 in the urease A gene and
were used in a secondary reaction to amplify a 120 nt
product from the 279 nt primary amplification product.
For both amplifications, cycling conditions were as fol-
lows: initial denaturation at 95°C for 5 minutes, followed
by 34 cycles of denaturation at 94°C for 1 minute, anneal-
ing at 53°C for 1 minute, and extension at 94°C for 1
minute. A final extension cycle was added, increasing the
72°C incubation to 5 minutes. Following amplification,
20 µl samples of each reaction were mixed with 5 µl gel
loading buffer (Sigma Biochemical, St. Louis, MO) and
electrophoresed in 3.0% Nusieve 3:1 agarose (FMC Bio-
products, Rockland, ME) gels.
Statistical analysis
Because culture of H. pylori (the generally accepted gold
standard) was not included in this study, statistical analy-
sis was limited to comparison of results obtained through
invasive methods (biopsy followed by CLOtest, histology,
and PCR) and those obtained using serology.
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